Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0423 per EA under NDC 76282020890. Its NADAC has been published 394 times since Dec 12, 2018.
Strength
40 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282020890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534On Market Since
10/1/2012
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 394 times since Dec 12, 2018, and over the history we have for it it has risen 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0347 (Oct 23, 2019) |
| 52-week high | $0.0464 |
| 52-week low | $0.0423 |
| Median price | $0.0395 |
| Average price | $0.0406 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 394 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0423 per EA (NDC 76282020890), effective Jun 24, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has risen 14.0%. It has been tracked across 394 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Dec 12, 2018, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0395 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CITALOPRAM HBR 40 MG TABLET, is $0.0386 per EA — about 9% below CITALOPRAM HBR 40 MG TABLET.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 76282020890) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification